Trial Profile
Randomized Comparison of Prophylactic and Pre-Emptive Imatinib Following Allogeneic Stem Cell Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2013
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 15 Dec 2011 New trial record